Vildag-M

Therapeutic Segment:

Generic Name:
Vildagliptin + Metformin HCl)

Description:
Vildag-M combines two oral hypoglycaemic agents with complimentary mechanisms of action to improve glycaemic control in patients with type 2 diabetes. Vildagliptin, a member of the islet enhancer class and Metformin, a member of the biguanide class.

Indication:

Vildag-M is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes whose diabetes is not adequately controlled on metformin hydrochloride alone or who are already treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. Treatment of type 2 diabetes should not be initiated with this fixed-dose combination.

Formulation:

  • Tablets

Strength:

  • 50mg/500mg
  • 50mg/850mg
  • 50mg/1000mg

Pack Size:

  • 1 x 14s
Vildag-packshot